FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2021/09/036556 [Registered on: 16/09/2021] Trial Registered Prospectively
Last Modified On: 15/09/2021
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Biological
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Comparison of characteristics of two drugs namely, CLONIDINE and FENTANYL as adjuncts to hyperbaric BUPIVACAINE, a drug commonly used for spinal anaesthesia in caesarean section 
Scientific Title of Study   Comparison of block characteristics of intrathecal CLONIDINE and FENTANYL as adjuncts to hyperbaric BUPIVACAINE in lower segment caesarean section  
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Pooja Mary Sebastian 
Designation  DNB TRAINEE 
Affiliation  Nazareth Hospital 
Address  Nazareth hospital , Laitumkrah Shillong

East Khasi Hills
MEGHALAYA
793003
India 
Phone  8746963175  
Fax    
Email  pooja.mary93@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Himjyoti Das 
Designation  HOD department of Anaesthesia 
Affiliation  Nazareth Hospital 
Address  Nazareth hospital , Laitumkrah Shillong
Laitumkrah Shillong,Meghalaya
East Khasi Hills
MEGHALAYA
793003
India 
Phone  9862018017  
Fax    
Email  himjyotidas@rediffmail.com  
 
Details of Contact Person
Public Query
 
Name  Pooja Mary Sebastian 
Designation  DNB TRAINEE 
Affiliation  Nazareth Hospital 
Address  Nazareth hospital , Laitumkrah Shillong

East Khasi Hills
MEGHALAYA
793003
India 
Phone  8746963175  
Fax    
Email  pooja.mary93@gmail.com  
 
Source of Monetary or Material Support  
Nazareth hospital Laitumkhrah, Shillong,Meghalaya 
 
Primary Sponsor  
Name  nazareth hospital 
Address  laitumkhrah shillong 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Pooja  Nazareth Hospital  department of anaesthesia
East Khasi Hills
MEGHALAYA 
8746963175

pooja.mary93@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
institutional ethics committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O998||Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium, (2) ICD-10 Condition: O998||Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  CLONIDINE  0.5mcg/kg of CLONIDINE added to 0.06mg/cm of intrathecal BUPIVACAINE for group 2 patients undergoing caesarean section 
Comparator Agent  FENTANYL  0.5mcg/kg of FENTANYL added to 0.06mg/cm of height of intrathecal BUPIVACAINE for group 1 patients undergoing caesarean section 
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  40.00 Year(s)
Gender  Female 
Details  1. Patients with singleton pregnancy, belonging to ASA grade I and II
2. Patients posted for elective and emergency LSCS
 
 
ExclusionCriteria 
Details  1.Patients with major neurological, cardiovascular, respiratory, renal, coagulation disorders
2.Patients with known hypersensitivity to local anaesthetics or study drugs.
3.Patients with local infection/spine deformity
4.Patients who refuse to give consent.
5.Patients whose height an weight cannot be measured before the surgery 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
To evaluate block characteristics of Intrathecal CLONIDINE versus FENTANYL as adjuncts to BUPIVACAINE in caesarean section  1 year 
 
Secondary Outcome  
Outcome  TimePoints 
to compare the levels of sedation and associated side effects with the 2 test drugs  1 year 
 
Target Sample Size   Total Sample Size="66"
Sample Size from India="66" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   20/09/2021 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   Not applicable 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This is a randomized comparative study designed with a primary objective to determine whether  doses of 0.5mcg/kg FENTANYL and 0.5mcg/kg CLONIDINE are equally effective when given as adjuncts to hyperbaric BUPIVACAINE 0.06mg/cm of height for spinal anaesthesia in LSCS. The study will compare the onset and duration of sensory and motor block, intraoperative hemodynamic parameters and  post operative analgesic requirement. Secondary objective of the study will be to compare the levels of sedation, and associated side effects with the 2 drugs. 
Close